Trial
NCT03748303
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arizona
Collaborators
University of Southern California; Alzheimer's Association
Condition
Alzheimer Dementia
Intervention
Allopregnanolone
Why stopped
Study interrupted by COVID-19 pandemic and could not be restarted at current location. Study investigators determined that relocating and continuing the study under its original scope was not feasible given preliminary results from IM injections.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-13